SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-22-000043
Filing Date
2022-08-08
Accepted
2022-08-08 17:01:09
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20220630.htm   iXBRL 10-Q 1561275
2 EX-31.1 anab-6302022x10qxexx311.htm EX-31.1 8562
3 EX-31.2 anab-6302022x10qxexx312.htm EX-31.2 8405
4 EX-32.1 anab-6302022x10qxexx321.htm EX-32.1 5087
5 EX-32.2 anab-6302022x10qxexx322.htm EX-32.2 4918
11 PIPELINE CHART anab-20220630_g1.jpg GRAPHIC 250440
  Complete submission text file 0001370053-22-000043.txt   7331409

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20220630.xsd EX-101.SCH 51145
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20220630_cal.xml EX-101.CAL 54617
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20220630_def.xml EX-101.DEF 199054
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20220630_lab.xml EX-101.LAB 554362
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20220630_pre.xml EX-101.PRE 348779
59 EXTRACTED XBRL INSTANCE DOCUMENT anab-20220630_htm.xml XML 1177026
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 221145235
SIC: 2834 Pharmaceutical Preparations